Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 166

1.

Methylene blue administration fails to confer neuroprotection in two amyotrophic lateral sclerosis mouse models.

Audet JN, Soucy G, Julien JP.

Neuroscience. 2012 May 3;209:136-43. doi: 10.1016/j.neuroscience.2011.12.047. Epub 2012 Jan 3.

PMID:
22230045
2.

Influence of methylene blue on microglia-induced inflammation and motor neuron degeneration in the SOD1(G93A) model for ALS.

Dibaj P, Zschüntzsch J, Steffens H, Scheffel J, Göricke B, Weishaupt JH, Le Meur K, Kirchhoff F, Hanisch UK, Schomburg ED, Neusch C.

PLoS One. 2012;7(8):e43963. doi: 10.1371/journal.pone.0043963. Epub 2012 Aug 27.

3.

Overexpression of Abeta is associated with acceleration of onset of motor impairment and superoxide dismutase 1 aggregation in an amyotrophic lateral sclerosis mouse model.

Li QX, Mok SS, Laughton KM, McLean CA, Volitakis I, Cherny RA, Cheung NS, White AR, Masters CL.

Aging Cell. 2006 Apr;5(2):153-65.

4.

PACAP signaling exerts opposing effects on neuroprotection and neuroinflammation during disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.

Ringer C, Büning LS, Schäfer MK, Eiden LE, Weihe E, Schütz B.

Neurobiol Dis. 2013 Jun;54:32-42. doi: 10.1016/j.nbd.2013.02.010. Epub 2013 Mar 4.

5.
6.

Molecular chaperone mediated late-stage neuroprotection in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.

Novoselov SS, Mustill WJ, Gray AL, Dick JR, Kanuga N, Kalmar B, Greensmith L, Cheetham ME.

PLoS One. 2013 Aug 30;8(8):e73944. doi: 10.1371/journal.pone.0073944. eCollection 2013.

7.

Mislocalization of TDP-43 in the G93A mutant SOD1 transgenic mouse model of ALS.

Shan X, Vocadlo D, Krieger C.

Neurosci Lett. 2009 Jul 17;458(2):70-4. doi: 10.1016/j.neulet.2009.04.031. Epub 2009 Apr 18.

PMID:
19379791
8.

Preservation of neuromuscular function in symptomatic SOD1-G93A mice by peripheral infusion of methylene blue.

Talbot JD, Barrett JN, Nonner D, Zhang Z, Wicomb K, Barrett EF.

Exp Neurol. 2016 Nov;285(Pt A):96-107. doi: 10.1016/j.expneurol.2016.08.013. Epub 2016 Aug 25.

PMID:
27567739
9.

TDP-43 modification in the hSOD1(G93A) amyotrophic lateral sclerosis mouse model.

Cai M, Lee KW, Choi SM, Yang EJ.

Neurol Res. 2015 Mar;37(3):253-62. doi: 10.1179/1743132814Y.0000000443. Epub 2014 Sep 12.

PMID:
25213598
10.

Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice--a model of familial amyotrophic lateral sclerosis.

Poon HF, Hensley K, Thongboonkerd V, Merchant ML, Lynn BC, Pierce WM, Klein JB, Calabrese V, Butterfield DA.

Free Radic Biol Med. 2005 Aug 15;39(4):453-62. Epub 2005 Apr 14.

PMID:
16043017
11.

Lack of effect of methylene blue in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.

Lougheed R, Turnbull J.

PLoS One. 2011;6(10):e23141. doi: 10.1371/journal.pone.0023141. Epub 2011 Oct 6.

12.

TDP-43 expression in mouse models of amyotrophic lateral sclerosis and spinal muscular atrophy.

Turner BJ, Bäumer D, Parkinson NJ, Scaber J, Ansorge O, Talbot K.

BMC Neurosci. 2008 Oct 28;9:104. doi: 10.1186/1471-2202-9-104.

13.

Phenotype of transgenic mice carrying a very low copy number of the mutant human G93A superoxide dismutase-1 gene associated with amyotrophic lateral sclerosis.

Deitch JS, Alexander GM, Bensinger A, Yang S, Jiang JT, Heiman-Patterson TD.

PLoS One. 2014 Jun 19;9(6):e99879. doi: 10.1371/journal.pone.0099879. eCollection 2014.

14.

Over-expression of Hsp27 does not influence disease in the mutant SOD1(G93A) mouse model of amyotrophic lateral sclerosis.

Krishnan J, Vannuvel K, Andries M, Waelkens E, Robberecht W, Van Den Bosch L.

J Neurochem. 2008 Sep;106(5):2170-83. doi: 10.1111/j.1471-4159.2008.05545.x. Epub 2008 Jul 4.

15.

Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.

Milanese M, Giribaldi F, Melone M, Bonifacino T, Musante I, Carminati E, Rossi PI, Vergani L, Voci A, Conti F, Puliti A, Bonanno G.

Neurobiol Dis. 2014 Apr;64:48-59. doi: 10.1016/j.nbd.2013.11.006. Epub 2013 Dec 19.

16.

Nuclear TAR DNA binding protein 43 expression in spinal cord neurons correlates with the clinical course in amyotrophic lateral sclerosis.

Sumi H, Kato S, Mochimaru Y, Fujimura H, Etoh M, Sakoda S.

J Neuropathol Exp Neurol. 2009 Jan;68(1):37-47. doi: 10.1097/NEN.0b013e3181919cb5.

PMID:
19104447
17.

Galectin-1 deficiency improves axonal swelling of motor neurones in SOD1(G93A) transgenic mice.

Kobayakawa Y, Sakumi K, Kajitani K, Kadoya T, Horie H, Kira J, Nakabeppu Y.

Neuropathol Appl Neurobiol. 2015 Feb;41(2):227-44. doi: 10.1111/nan.12123.

PMID:
24707896
18.

Neuroprotective effects of JGK-263 in transgenic SOD1-G93A mice of amyotrophic lateral sclerosis.

Ahn SW, Jeon GS, Kim MJ, Shon JH, Kim JE, Shin JY, Kim SM, Kim SH, Ye IH, Lee KW, Hong YH, Sung JJ.

J Neurol Sci. 2014 May 15;340(1-2):112-6. doi: 10.1016/j.jns.2014.03.008. Epub 2014 Mar 12.

PMID:
24680562
19.

Autophagy activation and neuroprotection by progesterone in the G93A-SOD1 transgenic mouse model of amyotrophic lateral sclerosis.

Kim J, Kim TY, Cho KS, Kim HN, Koh JY.

Neurobiol Dis. 2013 Nov;59:80-5. doi: 10.1016/j.nbd.2013.07.011. Epub 2013 Jul 26.

PMID:
23891729
20.

Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.

Jiang HQ, Ren M, Jiang HZ, Wang J, Zhang J, Yin X, Wang SY, Qi Y, Wang XD, Feng HL.

Neuroscience. 2014 Sep 26;277:132-8. doi: 10.1016/j.neuroscience.2014.03.047. Epub 2014 Mar 31.

PMID:
24699224

Supplemental Content

Support Center